Skip to main content
U.S. Department of Health and Human Services
—
National Institutes of Health
Create Account
Login
Main menu
Discover
Share
Create
Learn
The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB
Autogenerated by
for
edwinhui94
Created on Fri, 2022-10-21 10:58, last updated on Fri, 2022-10-21 10:58
I Printed This
Remix It
Vertical Tabs
General Information
This Model was autogenerated from the
"Quick Submit"
tool.
Model ID
3DPX-017725
Category
Proteins, Macromolecules and Viruses
Keyword(s)
PROTAC complex, targeted degradation, chromatin reader, ubiquitin ligase, bifunctional ligand, LIGASE
Protein Data Bank ID
5T35
Experimental Method
X-RAY DIFFRACTION
Resolution
2.700
Model Details
Associated Species
Escherichia coli BL21(DE3)
Oligomeric Details
tetrameric
R-Factor
0.2067
Scattering Type
x-ray
Attribution
PubMed ID
28 288 108
Digital Object Identifier (DOI)
10.1038/nchembio.2329
Citation Title
Structural basis of PROTAC cooperative recognition for selective protein degradation.
Journal
Nat. Chem. Biol.
Citation Year
2017
STL/VRML Files
PDB-5T35-ribbon-secondary.wrl
PDB-5T35-ribbon-rainbow.wrl
PDB-5T35-ribbon-bychain.wrl
PDB-5T35-ribbon.stl
PDB-5T35-surf-bychain.wrl
PDB-5T35-surf-hydropathy.wrl
PDB-5T35-surf-coulombic.wrl
PDB-5T35-surf.stl
PDB-5T35.zip
X3D Files
PDB-5T35-ribbon-secondary.x3d
PDB-5T35-ribbon-rainbow.x3d
PDB-5T35-ribbon-bychain.x3d
PDB-5T35-ribbon.x3d
PDB-5T35-surf-bychain.x3d
PDB-5T35-surf-hydropathy.x3d
PDB-5T35-surf-coulombic.x3d
PDB-5T35-surf.x3d
Rating
Select rating
Give The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB 1/5
Give The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB 2/5
Give The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB 3/5
Give The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB 4/5
Give The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB 5/5
Cancel rating
No votes yet
Licensing
Comments
0